ZA9810834B - Pyrrole compounds a process for their preparation and pharmaceutical compositions containing them - Google Patents
Pyrrole compounds a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA9810834B ZA9810834B ZA9810834A ZA9810834A ZA9810834B ZA 9810834 B ZA9810834 B ZA 9810834B ZA 9810834 A ZA9810834 A ZA 9810834A ZA 9810834 A ZA9810834 A ZA 9810834A ZA 9810834 B ZA9810834 B ZA 9810834B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- preparation
- compositions containing
- cycloalkyl
- pyrrole compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/72—4,7-Endo-alkylene-iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714840A FR2771412B1 (fr) | 1997-11-26 | 1997-11-26 | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9810834B true ZA9810834B (en) | 1999-05-31 |
Family
ID=9513802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9810834A ZA9810834B (en) | 1997-11-26 | 1998-11-26 | Pyrrole compounds a process for their preparation and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
US (2) | US6063804A (no) |
EP (1) | EP0921119B1 (no) |
JP (1) | JPH11228538A (no) |
CN (1) | CN1126737C (no) |
AT (1) | ATE244221T1 (no) |
AU (1) | AU739179B2 (no) |
BR (1) | BR9805053A (no) |
CA (1) | CA2254521C (no) |
DE (1) | DE69816004T2 (no) |
DK (1) | DK0921119T3 (no) |
ES (1) | ES2202775T3 (no) |
FR (1) | FR2771412B1 (no) |
HK (1) | HK1020945A1 (no) |
HU (1) | HUP9802749A2 (no) |
NO (1) | NO311716B1 (no) |
NZ (1) | NZ333000A (no) |
PL (1) | PL329894A1 (no) |
PT (1) | PT921119E (no) |
ZA (1) | ZA9810834B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
JP2003523954A (ja) * | 1999-12-08 | 2003-08-12 | ファルマシア コーポレイション | 治療効果が迅速に開始されるシクロオキシゲナーゼ−2阻害剤組成物 |
PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
US7695736B2 (en) | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
KR100821915B1 (ko) | 2006-11-10 | 2008-04-16 | 한양대학교 산학협력단 | 2번 위치에 엑소 메틸렌기를 가지는 고리화합물이 치환된 다중 고리화합물 및 이의 제조방법 |
WO2013155695A1 (en) * | 2012-04-20 | 2013-10-24 | Abbott Laboratories | Isoindolone derivatives |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2260213C (en) * | 1996-07-11 | 2005-03-29 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists |
-
1997
- 1997-11-26 FR FR9714840A patent/FR2771412B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-24 CA CA002254521A patent/CA2254521C/fr not_active Expired - Fee Related
- 1998-11-25 BR BR9805053-2A patent/BR9805053A/pt not_active IP Right Cessation
- 1998-11-25 NZ NZ333000A patent/NZ333000A/xx unknown
- 1998-11-25 DE DE69816004T patent/DE69816004T2/de not_active Expired - Fee Related
- 1998-11-25 US US09/199,640 patent/US6063804A/en not_active Expired - Fee Related
- 1998-11-25 EP EP98402926A patent/EP0921119B1/fr not_active Expired - Lifetime
- 1998-11-25 PL PL98329894A patent/PL329894A1/xx unknown
- 1998-11-25 NO NO19985495A patent/NO311716B1/no unknown
- 1998-11-25 AT AT98402926T patent/ATE244221T1/de not_active IP Right Cessation
- 1998-11-25 ES ES98402926T patent/ES2202775T3/es not_active Expired - Lifetime
- 1998-11-25 PT PT98402926T patent/PT921119E/pt unknown
- 1998-11-25 JP JP10333554A patent/JPH11228538A/ja active Pending
- 1998-11-25 DK DK98402926T patent/DK0921119T3/da active
- 1998-11-26 HU HU9802749A patent/HUP9802749A2/hu unknown
- 1998-11-26 ZA ZA9810834A patent/ZA9810834B/xx unknown
- 1998-11-26 CN CN98122801A patent/CN1126737C/zh not_active Expired - Fee Related
- 1998-11-26 AU AU94165/98A patent/AU739179B2/en not_active Ceased
-
1999
- 1999-09-03 US US09/390,416 patent/US6114360A/en not_active Expired - Fee Related
- 1999-12-03 HK HK99105666A patent/HK1020945A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE244221T1 (de) | 2003-07-15 |
HUP9802749A2 (hu) | 2001-02-28 |
US6114360A (en) | 2000-09-05 |
EP0921119A1 (fr) | 1999-06-09 |
CA2254521A1 (fr) | 1999-05-26 |
CN1126737C (zh) | 2003-11-05 |
US6063804A (en) | 2000-05-16 |
FR2771412B1 (fr) | 2000-04-28 |
NO985495D0 (no) | 1998-11-25 |
PT921119E (pt) | 2003-10-31 |
BR9805053A (pt) | 2000-02-01 |
AU9416598A (en) | 1999-06-17 |
NO985495L (no) | 1999-05-27 |
ES2202775T3 (es) | 2004-04-01 |
NO311716B1 (no) | 2002-01-14 |
EP0921119B1 (fr) | 2003-07-02 |
DK0921119T3 (da) | 2003-10-20 |
PL329894A1 (en) | 1999-06-07 |
NZ333000A (en) | 2000-04-28 |
CA2254521C (fr) | 2003-10-28 |
FR2771412A1 (fr) | 1999-05-28 |
DE69816004T2 (de) | 2004-04-29 |
CN1222509A (zh) | 1999-07-14 |
DE69816004D1 (de) | 2003-08-07 |
JPH11228538A (ja) | 1999-08-24 |
HK1020945A1 (en) | 2000-05-26 |
HU9802749D0 (en) | 1999-01-28 |
AU739179B2 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9203318D0 (sv) | Novel 3,3-diphenylpropylamines, their use and preparation | |
HUT41761A (en) | Process for producing tricyclic aromatic compounds | |
ZA909901B (en) | Peptide compounds,a process for preparation thereof and pharmaceutical composition comprising the same | |
GEP20053541B (en) | Pyrrolo[2,3-d]Pyrimidine Compounds | |
DE68926403D1 (de) | Peptid-Verbindungen, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzung | |
DE68917023D1 (de) | 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen. | |
DE69130412T2 (de) | Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung | |
ZA9810834B (en) | Pyrrole compounds a process for their preparation and pharmaceutical compositions containing them | |
HK1023346A1 (en) | Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them | |
PL326554A1 (en) | Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase | |
DE3787844D1 (de) | Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen. | |
GB1415471A (en) | Phenylethylamine derivatives | |
HRP20000733B1 (en) | NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS | |
IL89538A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
IL89537A0 (en) | Peptides,their preparation and pharmaceutical compositions containing them | |
AU586089B2 (en) | Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure | |
ATE97902T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung. |